This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Assié, G. Articles by Bertagna, X. Search for Related Content PubMed PubMed Citation Articles by Assié, G. Articles by Bertagna, X. Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary Endocrine Oncology

Corticotroph Tumor Progression after Adrenalectomy in Cushing’s Disease: A Reappraisal of Nelson’s Syndrome

Departments of Endocrinology (G.A., F.K., J.B., X.B.), Biophysics and Hormonology (M.-A.D.), and Digestive and Endocrine Surgery (B.D.), Cochin Hospital, Faculté René Descartes, Paris 5 University, Centre de Référence des Maladies Rares de la Surrénale, and Department of Radiology A (H.B., S.S., P.L.), Statistics and Medical Informatics (J.C.), and Department of Endocrinology-Metabolism-Cancer (G.A., J.B., X.B.), Institut National de la Santé et de la Recherche Médicale U567 and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8104, Cochin Institute, 75014 Paris, France; and Department of Neuropathology (M.K.), Laboratoire R. Escourolle, Pitié Salpétrière Hospital, Paris 6 University, 75013 Paris, France

Address all correspondence and requests for reprints to: Xavier Bertagna, Department of Endocrinology, Cochin Hospital, 27, rue du Fg St. Jacques, 75014 Paris, France. E-mail: xavier.bertagna{at}cch.aphp.fr.

Context: Adrenalectomy is a radical treatment for hypercortisolism in Cushing’s disease. However, it may lead to Nelson’s syndrome, originally defined by the association of a pituitary macroadenoma and high plasma ACTH concentrations, a much feared complication.

Objective: The objective of the study was to reconsider Nelson’s syndrome by investigating corticotroph tumor progression based on pituitary magnetic resonance imaging scan and search for predictive factors.

Design: This was a retrospective cohort study.

Setting: The complete medical records of Cushing’s disease patients at Cochin Hospital were studied.

Patients: Patients included 53 Cushing’s disease patients treated by adrenalectomy between 1991 and 2002, without previous pituitary irradiation.

Measurements: Clinical data, pituitary magnetic resonance imaging data, and plasma ACTH concentrations for all patients and pituitary gland pathology data for 25 patients were recorded. Corticotroph tumor progression-free survival was studied by Kaplan-Meier, and the influence of recorded parameters was studied by Cox regression.

Intervention: There was no intervention.

Results: Corticotroph tumor progression ultimately occurred in half the patients, generally within 3 yr after adrenalectomy. A shorter duration of Cushing’s disease (adjusted hazard ratio: 0.884/yr), and a high plasma ACTH concentration in the year after adrenalectomy [adjusted hazard ratio per 100 pg/ml (22 pmol/liter): 1.069] were predictive of corticotroph tumor progression. In one case, corticotroph tumor progression was complicated by transitory oculomotor nerve palsy. During follow-up, corticotroph tumor progression was associated with the increase of corresponding ACTH concentrations (odds ratio per 100 pg/ml of ACTH variation: 1.055).

Conclusion: After adrenalectomy in Cushing’s disease, one should no longer wait for the occurrence of Nelson’s syndrome: modern imaging allows early detection and management of corticotroph tumor progression.

This article has been cited by other articles:

				I. Benoit, D. Drui, L. Chaillous, B. Dupas, J.-F. Mosnier, B. Charbonnel, and B. Cariou A corticotroph pituitary adenoma as the initial presentation of familial glucocorticoid deficiency Eur. J. Endocrinol., July 1, 2009; 161(1): 195 - 199. [Abstract] [Full Text] [PDF]

				E. O. Vik-Mo, M. Oksnes, P.-H. Pedersen, T. Wentzel-Larsen, E. Rodahl, F. Thorsen, T. Schreiner, S. Aanderud, and M. Lund-Johansen Gamma knife stereotactic radiosurgery of Nelson syndrome Eur. J. Endocrinol., February 1, 2009; 160(2): 143 - 148. [Abstract] [Full Text] [PDF]

				V J Moyes, G Alusi, H I Sabin, J Evanson, D M Berney, K Kovacs, J P Monson, P N Plowman, and W M Drake Treatment of Nelson's syndrome with temozolomide Eur. J. Endocrinol., January 1, 2009; 160(1): 115 - 119. [Abstract] [Full Text] [PDF]

				P. Bougneres, L. Pantalone, A. Linglart, A. Rothenbuhler, and C. Le Stunff Endocrine Manifestations of the Rapid-Onset Obesity with Hypoventilation, Hypothalamic, Autonomic Dysregulation, and Neural Tumor Syndrome in Childhood J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3971 - 3980. [Abstract] [Full Text] [PDF]

				B. M. K. Biller, A. B. Grossman, P. M. Stewart, S. Melmed, X. Bertagna, J. Bertherat, M. Buchfelder, A. Colao, A. R. Hermus, L. J. Hofland, et al. Treatment of Adrenocorticotropin-Dependent Cushing's Syndrome: A Consensus Statement J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2454 - 2462. [Abstract] [Full Text] [PDF]

				S. Melmed Update in Pituitary Disease J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 331 - 338. [Abstract] [Full Text] [PDF]

				F Castinetti, I Morange, P Jaquet, B Conte-Devolx, and T Brue Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease Eur. J. Endocrinol., January 1, 2008; 158(1): 91 - 99. [Abstract] [Full Text] [PDF]